This company’s potential far exceeds its risks. Intuitive Surgical (ISRG 3.26%) has been thriving since its inception in 1995, becoming a leader in robotic surgery with its da Vinci system. The increasing adoption of robotic-assisted surgery has led to growing revenue and earnings for the company, with significant long-term opportunities ahead.
Despite facing some headwinds, such as pandemic-related disruptions and competition in the market, Intuitive Surgical remains well-positioned for continued success. With a strong competitive advantage, consistent revenue and earnings, and a track record of excellence, the company is a solid long-term investment. Consider adding Intuitive Surgical to your portfolio for the next decade.